TCM BIOTECH INT CORP has a total of 19 patent applications. It increased the IP activity by 1100.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are FUJIAN ACAD OF MEDICAL SCIENCES, BEIJING ZHICHENG BIOMEDICAL TECH CO LTD and BLUM KENNETH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Taiwan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Republic of Korea | 2 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Measuring microorganism processes | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Analysing materials | |
#7 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Wang Ya-Chun | 11 |
#2 | Tzeng Sheng-Tai | 8 |
#3 | Lin You-Yu | 6 |
#4 | Wang Ya Chun | 4 |
#5 | Wang Yachun | 4 |
#6 | Chen Jenyau | 4 |
#7 | Chen Jen-Yau | 3 |
#8 | Chen Ding-Shinn | 2 |
#9 | Yeh Shiou-Hwei | 2 |
#10 | Meng En | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020216333A1 | Pharmaceutical composition for prevention of recurrent urinary tract infection | |
US2019233524A1 | Therapeutic combination and method for treating cancer | |
US2018223380A1 | Probe combination for detection of cancer | |
US2018113137A1 | Method for detecting the quantity of biomarker and identifying disease status | |
TW201538166A | Pharmaceutical composition for the treatment of adult growth hormone deficiency syndrome | |
EP2644201A1 | Pharmaceutical composition for preventing and treating liver fibrosis or nonalcoholic fatty liver disease |